Simple blood test could catch myeloma years earlier in High-Risk groups
NCT ID NCT06644625
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This study aims to find multiple myeloma at its earliest, precancerous stage (MGUS) in people at higher risk—Black adults and those with a family history of plasma cell disorders. By screening with a simple blood test, researchers hope to catch the disease before it causes serious harm, reducing delays in diagnosis and improving long-term health. About 1,665 participants will be enrolled to see how many can be screened and how many have MGUS.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atrium Health Levine Cancer
RECRUITINGCharlotte, North Carolina, 28204, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.